G-Protein-linked Receptor Interactions [MoA] - N0000000152

Name: Table of NDC products with g-protein-linked receptor interactions
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000000152
Pharmacologic Name	G-Protein-linked Receptor Interactions
Pharmacologic Uses	glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with G-Protein-linked Receptor Interactions

The table contains 24 products whose active ingredient are classified under the same pharmacologic class G-Protein-linked Receptor Interactions [MoA].

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
0002-0152	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-0243	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-1152	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-1214	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-1243	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-1340	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-1423	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-1457	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-1460	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-1471	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-1484	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-1495	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-1506	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-2002	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-2214	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-2340	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-2423	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-2457	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-2460	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-2471	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-2484	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-2495	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-2506	Zepbound	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE
0002-3002	Mounjaro	Non-Proprietary Name: Tirzepatide	Injection, Solution	Subcutaneous	Eli Lilly And Company	ACTIVE